Results 91 to 100 of about 25,533 (219)

A Proactive Approach to Womens Concerns: Womens Longevity Groups and Funds [PDF]

, 2005
With the exception of ten countries in the world, according to the World Health Organization's 2005 report, women outlive men. In the United States, women outlive men by 5.3 years.
Myrna I. Lewis
core  

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents [PDF]

, 2015
Medications to inhibit the actions of tumour necrosis factor alpha have revolutionized the treatment of several pro-inflammatory autoimmune conditions.
Bonacini, Maurizio, Bonkovsky, Herbert L., Foureau, David, French, Joshua B., Ghabril, Marwan   +4 more
core   +2 more sources

Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures

Pharmacy Practice, 2006
Objective: The objective of this study was to identify problems in the approval, pharmacovigilance, and post-approval regulatory decision-making procedures involving gefitinib and to propose countermeasures to prevent further drug-induced suffering in ...
Nishimura T,, Tada H, Nakagawa M, Teramukai S, Matsui S, Fukushima M   +5 more
doaj  

Post-Marketing Surveillance of a generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer

Current Therapeutic Research, 2022
: Background: CRC is the second and third most common cancer in women and men, respectively. The national comprehensive cancer network guidelines recommend oxaliplatin-based chemotherapy as a preferred regimen for patients with advanced or metastatic ...
Farhad Shahi, Mojtaba Gorji, Assistant Professor of Pediatric Oncology, Mehrdad Payandeh, Assistant Professor of Hematology & Oncology, Hamid Rezvani, Associate Professor of Hematology & Oncology, Mohammad Vaezi, Associate Professor of Hematology & Oncology, Sharareh Seifi, Assistant Professor of Hematology & Oncology, Alireza Baari, Post doctoral fellowship, Reza Khalili-Dizaji, Post doctoral fellowship, Seyed Mehdi Hashemi, Associate Professor of Hematology & Oncology, Saeid Salimi, post doctoral fellowship, Hosein Kamranzadeh, Associate Professor of Hematology & Oncology, Babak Shazad, Post doctoral fellowship, Sina Salari, Associate Professor of Hematology & Oncology, Davoud Oulad Dameshghi, Assistant Professor of Hematology & Oncology, Mehdi Sarkheil, Post doctoral fellowship, Mehrzad Mirzania, Associate Professor of Hematology & Oncology, Nassim Anjidani, Pharm. D.   +16 more
doaj  

The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non–small cell lung cancer

Cancer, Volume 130, Issue 24, Page 4188-4199, 15 December 2024.
Abstract Comprehensive biomarker testing is a crucial requirement for the optimal treatment of advanced‐stage non–small cell lung cancer (NSCLC), with emerging relevance in the adjuvant treatment setting. To advance its goal of ensuring optimal therapy for persons diagnosed with lung cancer, the American Cancer Society National Lung Cancer Roundtable ...
Adam H. Fox, Raymond U. Osarogiagbon, Farhood Farjah, James R. Jett, Bruce E. Johnson, M. Patricia Rivera, Robert A. Smith, Ignacio I. Wistuba, Gerard A. Silvestri   +8 more
wiley   +1 more source

DRUG THERAPY AND PREGNANCY: UNKNOWN RISKS LEAD TO HARD CHOICES [REDACTED VERSION] [PDF]

, 2012
This paper is a proposal to improve the quality of information available to pregnant patients in selecting treatment options. By providing drug companies with extended grants of exclusivity, the FDA has the ability to empower pregnant women to take ...
Goldstein, Lori M.
core  

Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope in children requiring growth hormone treatment

Therapeutic Advances in Endocrinology and Metabolism, 2013
Objective: To describe the rationale, design and first data from PATRO Children, a postmarketing surveillance of the long-term efficacy and safety of somatropin (Omnitrope ® ) for the treatment of children requiring growth hormone treatment.
Roland Pfäffle, Karl Otfried Schwab, Otilia Marginean, Mieczyslaw Walczak, Mieczyslaw Szalecki, Ellen Schuck, Markus Zabransky, Stefano Zucchini   +7 more
doaj   +1 more source

Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept [PDF]

, 2014
A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to ...
Deidda, Arianna, Garau, Donatella, Longu, Maria Giovanna, Moretti, Grazia Maria Rita, Moretti, Mario Domenico Luigi, Pisanu, Claudia, Sanna, Maria Elena, Stochino, Maria Eminia   +7 more
core   +1 more source

Development of instrument to report and asses causality of adverse events related to herbal medicines

Vitae, 2017
Background: The use of herbal medicines is justified empirically using ethnopharmacological knowledge, which has limitations. Reports of adverse events (AE) may contribute for safety, quality, and effectiveness assessment. Objectives: This study aimed to
Patricia de Carvalho MASTROIANNI, Fabiana ROSSI VARALLO, Marília AMARAL COSTA, Luís Vitor Da Silva SACRAMENTO   +3 more
doaj  

The US Food and Drug Administration’s expedited approval programs: addressing premarket flexibility with enhanced postmarket evidence generation [PDF]

, 2018
When the editors of Clinical Trials solicited our review on the U.S. Food and Drug Administration’s (FDA) expedited development and review programs, we anticipated there would be accompanying commentaries from other academics with differing opinions, or ...
Naci, Huseyin, Ross, Joseph S., Wallach, Joshua D.   +2 more
core   +1 more source